Question to Ohm re LL efficacy for Omicron. Dea
Post# of 148110
Dear ohm, what is your thinking on LL vs Omicron in the light of the FDA revoking the EUA for monoclonal antibodies from Regeneron and Eli Lilly because they are unlikely to work against the omicron variant?
CytoDyn Inc (CYDY) Stock Research Links
Le-Ron-Li-Mab, and they have not.